Chen X, Sun F, Wang X, Feng X, Aref A, Tian Y
Cancer Cell Int. 2025; 25(1):62.
PMID: 39987122
PMC: 11847367.
DOI: 10.1186/s12935-025-03673-6.
Cau R, Saba L
Cardiovasc Diagn Ther. 2025; 14(6):1186-1201.
PMID: 39790197
PMC: 11707487.
DOI: 10.21037/cdt-24-344.
Chen Y, Luo Y, Liu Y, Luo D, Liu A
Cancer Immunol Immunother. 2025; 74(2):52.
PMID: 39752010
PMC: 11699076.
DOI: 10.1007/s00262-024-03899-9.
Hashimoto A, Hashimoto S
Cancers (Basel). 2024; 16(23).
PMID: 39682280
PMC: 11640101.
DOI: 10.3390/cancers16234094.
Lynch D, Forrester B, Webb T, Ciulli A
Front Immunol. 2024; 15:1449397.
PMID: 39676878
PMC: 11638205.
DOI: 10.3389/fimmu.2024.1449397.
Practical application of melatonin for pancreas disorders: protective roles against inflammation, malignancy, and dysfunctions.
Sheibani M, Hosseinzadeh A, Fatemi I, Naeini A, Mehrzadi S
Pharmacol Rep. 2024; .
PMID: 39604705
DOI: 10.1007/s43440-024-00683-5.
Inflammatory Processes: Key Mediators of Oncogenesis and Progression in Pancreatic Ductal Adenocarcinoma (PDAC).
Yang L, Qiao S, Zhang G, Lu A, Li F
Int J Mol Sci. 2024; 25(20).
PMID: 39456771
PMC: 11506938.
DOI: 10.3390/ijms252010991.
Safety and efficacy of itacitinib, a selective JAK1 inhibitor, in advanced hepatocellular cancer: Phase 1b trial (JAKAL).
Troiani A, Martinez M, Ward C, Benartzi C, Pinato D, Sharma R
Future Oncol. 2024; 20(36):2839-2847.
PMID: 39283290
PMC: 11572186.
DOI: 10.1080/14796694.2024.2396795.
Cytokines and Pancreatic Ductal Adenocarcinoma: Exploring Their Relationship with Molecular Subtypes and Prognosis.
Gutierrez-Sainz L, Heredia-Soto V, Rodriguez-Garcia A, Crespo Sanchez M, Serrano-Olmedo M, Molero-Luis M
Int J Mol Sci. 2024; 25(17).
PMID: 39273323
PMC: 11395259.
DOI: 10.3390/ijms25179368.
Role of Interleukins in Pancreatic Cancer: A Literature Review.
Rafaqat S, Khurshid H, Hafeez R, Arif M, Zafar A, Gilani M
J Gastrointest Cancer. 2024; 55(4):1498-1510.
PMID: 39256264
DOI: 10.1007/s12029-024-01111-w.
TIM-4 increases the proportion of CD4CD25FOXP3 regulatory T cells in the pancreatic ductal adenocarcinoma microenvironment by inhibiting IL-6 secretion.
Wang Z, Xie Z, Mou Y, Geng R, Chen C, Ke N
Cancer Med. 2024; 13(17):e70110.
PMID: 39235042
PMC: 11375529.
DOI: 10.1002/cam4.70110.
A Narrative Review: Immunometabolic Interactions of Host-Gut Microbiota and Botanical Active Ingredients in Gastrointestinal Cancers.
Li S, Feng W, Wu J, Cui H, Wang Y, Liang T
Int J Mol Sci. 2024; 25(16).
PMID: 39201782
PMC: 11354385.
DOI: 10.3390/ijms25169096.
STAT3 Increases CVB3 Replication and Acute Pancreatitis and Myocarditis Pathology via Impeding Nuclear Translocation of STAT1 and Interferon-Stimulated Gene Expression.
Liang T, Zhang Z, Bai Z, Xu L, Xu W
Int J Mol Sci. 2024; 25(16).
PMID: 39201692
PMC: 11354559.
DOI: 10.3390/ijms25169007.
Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment.
Vitorakis N, Gargalionis A, Papavassiliou K, Adamopoulos C, Papavassiliou A
Cancers (Basel). 2024; 16(16).
PMID: 39199647
PMC: 11352254.
DOI: 10.3390/cancers16162876.
Focus on Pancreatic Cancer Microenvironment.
Prattico F, Garajova I
Curr Oncol. 2024; 31(8):4241-4260.
PMID: 39195299
PMC: 11352508.
DOI: 10.3390/curroncol31080316.
B7 homolog 3 in pancreatic cancer.
Perovic D, Dusanovic Pjevic M, Perovic V, Grk M, Rasic M, Milickovic M
World J Gastroenterol. 2024; 30(31):3654-3667.
PMID: 39193002
PMC: 11346158.
DOI: 10.3748/wjg.v30.i31.3654.
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer.
Casacuberta-Serra S, Gonzalez-Larreategui I, Capitan-Leo D, Soucek L
Signal Transduct Target Ther. 2024; 9(1):205.
PMID: 39164274
PMC: 11336233.
DOI: 10.1038/s41392-024-01907-z.
Interleukin-6 serves as a critical factor in various cancer progression and therapy.
Mohamed A, Ahmed A, Al Abdulmonem W, Olegovich Bokov D, Shafie A, Al-Hetty H
Med Oncol. 2024; 41(7):182.
PMID: 38900329
DOI: 10.1007/s12032-024-02422-5.
An oncogenic enhancer promotes melanoma progression via regulating ETV4 expression.
Zhang J, Wang Q, Qi S, Duan Y, Liu Z, Liu J
J Transl Med. 2024; 22(1):547.
PMID: 38849954
PMC: 11157841.
DOI: 10.1186/s12967-024-05356-8.
NEMO/NF-κB signaling functions as a double-edged sword in PanIN formation versus progression to pancreatic cancer.
Tsesmelis M, Buttner U, Gerstenlauer M, Manfras U, Tsesmelis K, Du Z
Mol Cancer. 2024; 23(1):103.
PMID: 38755681
PMC: 11097402.
DOI: 10.1186/s12943-024-01989-x.